European Journal of Nutrition

, Volume 51, Issue 7, pp 769–781 | Cite as

Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary

Review

Abstract

Purpose

Experimental evidence indicates a strong connection between oxidative damage, cancer, and aging. Epidemiological observations suggest that a diet rich in fruits and vegetables is associated with lower incidence of some cancers and longer life expectancy; since fruits and vegetables contain natural antioxidants, a considerable effort has been dedicated to understanding their effects in experimental studies and in human trials.

Results

A: Effects of antioxidant-containing food and supplements on oxidation damage in humans. Intervention trials employing a variety of biomarkers have shown either a slight decrease in oxidation damage or no effect. B: Effects of selected antioxidants on mortality and cancer incidence. β-carotene and α-tocopherol, alone or in combination, increase cardiovascular and all-cause mortality or have no effect. In some studies, β-carotene and retinyl palmitate significantly increase the progression of lung cancer and aggressive prostate cancer. Protection against cardiovascular mortality or no effect of vitamin E has been reported, with an increase of all-cause mortality at dosages greater than 150 IU/day. Selenium showed beneficial effects on gastrointestinal cancer and reduced the risk of lung cancer in populations with lower selenium status. For multivitamin and mineral supplementation, no significant reduction of mortality or cancer incidence was observed, but some reports indicate a possible preventive effect in cervical cancer.

Conclusions

The majority of supplementation studies indicate no variation of general mortality and of cancer incidence or a detrimental effect on both. Antioxidant supplements so far tested seem to offer no improvement over a well-balanced diet, possibly because of the choice of the substances tested or of an excessive dosage. However, new natural or synthetic compounds effective in vitro and in experimental studies might still be worth investigating in human trials.

Keywords

Free radicals Antioxidants Aging Cancer 

References

  1. 1.
    Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298–300Google Scholar
  2. 2.
    Adelman R, Saul RL, Ames BN (1988) Oxidative damage to DNA: relation to species metabolic rate and lifespan. Proc Natl Acad Sci USA 85(8):2706–2708CrossRefGoogle Scholar
  3. 3.
    Peto R, Doll R, Buckley JD, Sporn MB (1981) Can dietary beta-carotene materially reduce human cancer rates? Nature 290(5803):201–208CrossRefGoogle Scholar
  4. 4.
    Singh PM, Sabaté J, Fraser GR (2003) Does low meat consumption increase life expectancy in humans. Am J Clin Nutr 78(suppl):526S–532SGoogle Scholar
  5. 5.
    Fortes C, Forastiere F, Farchi S, Rapiti E, Pastori G, Perucci CA (2000) Diet and overall survival in a cohort of very elderly people. Epidemiology 4:440–445CrossRefGoogle Scholar
  6. 6.
    American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research (1997) Food, nutrition, and the prevention of cancer: a global perspective. Washington DC, USAGoogle Scholar
  7. 7.
    American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research (2007) Food, nutrition, PHYSICAL ACTIVITY and the prevention of cancer: a global perspective, Washington DC, USAGoogle Scholar
  8. 8.
    Stähelin HB, Gey KF, Eichholzer M, Lüdin E (1991) Beta-carotene and cancer prevention: the Basel Study. Am J Clin Nutr 53(1 Suppl):265S–269SGoogle Scholar
  9. 9.
    Chen J, Geissler C, Parpia B, Li J, Campbell TC (1992) Antioxidant status and cancer mortality in China. Int J Epidemiol 21(4):625–635CrossRefGoogle Scholar
  10. 10.
    Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, Mandel JS, Haile RW (1996) Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 275(9):699–703CrossRefGoogle Scholar
  11. 11.
    Tsubono Y, Tsugane S, Gey KF (1999) Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer 34(1):56–61CrossRefGoogle Scholar
  12. 12.
    Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006) Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the α-Tocopherol, β-Carotene Cancer Prevention Study. Am J Clin Nutr 84(5):1200–1207Google Scholar
  13. 13.
    Yuan JM, Ross RK, Gao YT, Qu YH, Chu XD, Yu MC (2004) Prediagnostic levels of serum micronutrients in relation to risk of gastric cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 13(11 Pt 1):1772–1780Google Scholar
  14. 14.
    Watters JL, Gail MH, Weinstein SJ, Virtamo J, Albanes D (2009) Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res 69(9):3833–3841CrossRefGoogle Scholar
  15. 15.
    Buijsse B, Feskens EJ, Schlettwein-Gsell D, Ferry M, Kok FJ, Kromhout D, de Groot LC (2005) Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA). Am J Clin Nutr 82(4):879–886Google Scholar
  16. 16.
    Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJ, Ma JA (2010) Large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila) 3(5):604–610CrossRefGoogle Scholar
  17. 17.
    Lauretani F, Semba RD, Dayhoff-Brannigan M, Corsi AM, Di Iorio A, Buiatti E, Bandinelli S, Guralnik JM, Ferrucci L (2010) Low total plasma carotenoids are independent predictors of mortality among older persons: the InCHIANTI study. Eur J Nutr 47(6):335–340CrossRefGoogle Scholar
  18. 18.
    Shardell MD, Alley DE, Hicks GE, El-Kamary SS, Miller RR, Semba RD, Ferrucci L (2011) Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey. Nutr Res 31(3):178–189CrossRefGoogle Scholar
  19. 19.
    Brevik A, Andersen LF, Karlsen A, Trygg KU, Blomhoff R, Drevon CA (2004) Six carotenoids in plasma used to assess recommended intake of fruits and vegetables in a controlled feeding study. Eur J Clin Nutr 58(8):1166–1173CrossRefGoogle Scholar
  20. 20.
    Kažimírová A, Barancoková M, Volkovová K, Staruchová M, Krajcovicová-Kudlácková M, Wsólová L, Collins AR, Dušinská M (2004) Does a vegetarian diet influence genomic stability? Eur J Nutr 43:32–38CrossRefGoogle Scholar
  21. 21.
    Dhawan A, Mathur N, Seth PK (2001) The effect of smoking and eating habits on DNA damage in Indian population as measured in the Comet assay. Mutat Res 474:121–128CrossRefGoogle Scholar
  22. 22.
    Fenech M, Rinaldi J (1995) A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians. Carcinogenesis 16:223–230CrossRefGoogle Scholar
  23. 23.
    Krajcovicová-Kudlácková M, Valachovicová M, Pauková V, Dusinská M (2008) Effects of diet and age on oxidative damage products in healthy subjects. Physiol Res 57(4):647–651Google Scholar
  24. 24.
    Somannavar MS, Kodliwadmath MV (2012) Correlation between oxidative stress and antioxidant defence in South Indian urban vegetarians and non-vegetarians. Eur Rev Med Pharmacol Sci 16(3):351–354Google Scholar
  25. 25.
    Collins AR, Olmedilla B, Southon S, Granado F, Duthie SJ (1998) Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis 19(12):2159–2162CrossRefGoogle Scholar
  26. 26.
    Giovannelli L, Saieva C, Masala G, Testa G, Salvini S, Pitozzi V, Riboli E, Dolara P, Palli D (2002) Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population. Carcinogenesis 23:1483–1489CrossRefGoogle Scholar
  27. 27.
    Dusinska M, Vallova B, Ursinyova M, Hladikova V, Smolkova B, Wsolova L, Raslova K, Collins AR (2002) DNA damage and antioxidants; fluctuations through the year in a central European population group. Food Chem Toxicol 40:1119–1123CrossRefGoogle Scholar
  28. 28.
    Agarwal S, Sohal RS (2004) DNA oxidative damage and life expectancy in houseflies. Proc Natl Acad Sci USA 91(25):12332–12335CrossRefGoogle Scholar
  29. 29.
    Sohal RS, Kamzalov S, Sumien N, Ferguson M, Rebrin I, Heinrich KR, Forster MJ (2006) Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and lifespan of mice. Free Radic Biol Med 40(3):480–487CrossRefGoogle Scholar
  30. 30.
    Arking R, Burde V, Graves K, Hari R, Feldman E, Zeevi A, Soliman S, Saraiya A, Buck S, Vettraino J, Sathrasala K, Wehr N, Levine RL (2000) Forward and reverse selection for longevity in Drosophila is characterized by alteration of antioxidant gene expression and oxidative damage patterns. Exp Gerontol 35(2):167–185CrossRefGoogle Scholar
  31. 31.
    Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92(10):4337–4341CrossRefGoogle Scholar
  32. 32.
    Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS (2005) Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 308(5730):1909–1911CrossRefGoogle Scholar
  33. 33.
    Zhang Y, Ikeno Y, Qi W, Chaudhuri A, Li Y, Bokov A, Thorpe SR, Baynes JW, Epstein C, Richardson A, Van Remmen H (2009) Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci 64(12):1212–1220CrossRefGoogle Scholar
  34. 34.
    Van Raamsdonk JM, Meng Y, Camp D, Yang W, Jia X, Bénard C, Hekimi S (2010) Decreased energy metabolism extends lifespan in Caenorhabditis elegans without reducing oxidative damage. Genetics 185(2):559–571CrossRefGoogle Scholar
  35. 35.
    Cabreiro F, Ackerman D, Doonan R, Araiz C, Back P, Papp D, Braeckman BP, Gems D (2011) Increased lifespan from overexpression of superoxide dismutase in Caenorhabditis elegans is not caused by decreased oxidative damage. Free Radic Biol Med 51(8):1575–1582CrossRefGoogle Scholar
  36. 36.
    Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvári M, Piper MD, Hoddinott M, Sutphin GL, Leko V, McElwee JJ, Vazquez-Manrique RP, Orfila AM, Ackerman D, Au C, Riesen M, Howard K, Neri C, Bedalov A, Kaeberlein M, Soti C, Partridge L, Gems D (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477(7365):482–485CrossRefGoogle Scholar
  37. 37.
    Porta EA, Joun NS, Nitta RT (1980) Effects of the type of dietary fat at two levels of vitamin E in Wistar male rats during development and aging. I. Lifespan, serum biochemical parameters and pathological changes. Mech Aging Dev 13(1):1–39CrossRefGoogle Scholar
  38. 38.
    Massie HR, Aiello VR, Doherty TJ (1984) Dietary vitamin C improves the survival of mice. Gerontology 30(6):371–375CrossRefGoogle Scholar
  39. 39.
    Massie HR, Ferreira JR Jr, DeWolfe LK (1986) Effect of dietary beta-carotene on the survival of young and old mice. Gerontology 32(4):189–195CrossRefGoogle Scholar
  40. 40.
    Thomas J, Nyberg D (1988) Vitamin E supplementation and intense selection increase clonal lifespan in Paramecium tetraurelia. Exp Gerontol 23(6):501–512CrossRefGoogle Scholar
  41. 41.
    Mahajan S, Garg SK, Lobana TS (1994) Effect of BHA on longevity, antioxygenic enzymes and peroxides in Callosobruchus maculatus. Exp Gerontol 29(5):585–591CrossRefGoogle Scholar
  42. 42.
    Edamatsu R, Mori A, Packer L (1995) The spin-trap N-tert-alpha-phenyl-butylnitrone prolongs the lifespan of the senescence accelerated mouse. Biochem Biophys Res Commun 211(3):847–849CrossRefGoogle Scholar
  43. 43.
    Kumari MV, Yoneda T, Hiramatsu M (1997) Effect of “beta CATECHIN” on the life span of senescence accelerated mice (SAM-P8 strain). Biochem Mol Biol Int 41(5):1005–1011Google Scholar
  44. 44.
    Holloszy JO (1998) Longevity of exercising male rats: effect of an antioxidant supplemented diet. Mech Aging Dev 100(3):211–219CrossRefGoogle Scholar
  45. 45.
    Cui X, Dai XG, Li WB, Zhang BL, Fang YZ (1999) Effects of lu-duo-wei capsule on prolonging lifespan of housefly and Drosophila melanogaster. Am J Chin Med 27(3–4):407–413CrossRefGoogle Scholar
  46. 46.
    Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow SR, Lithgow GJ (2000) Extension of lifespan with superoxide dismutase/catalase mimetics. Science 289(5484):1567–1569CrossRefGoogle Scholar
  47. 47.
    ESCODD, Gedik CM, Collins A (2004) Establishing the background level of base oxidation in human lymphocyte DNA: results of an inter-laboratory validation study. FASEB J. www.fasebj.org/cgi/doi/10.1096/fj.04-1767fje
  48. 48.
    Møller P, Loft S (2004) Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res 551:79–89CrossRefGoogle Scholar
  49. 49.
    Duthie SJ, Ma A, Ross MA, Collins AR (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 56(6):1291–1295Google Scholar
  50. 50.
    Møller P, Viscovich M, Lykkesfeld J, Loft S, Jensen A, Poulsen HE (2004) Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers. Eur J Nutr 43:267–274CrossRefGoogle Scholar
  51. 51.
    Collins AR, Harrington V, Drew J, Melvin R (2003) Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis 24:511–515CrossRefGoogle Scholar
  52. 52.
    Thompson HJ, Heimendinger J, Sedlacek S, Haegele A, Diker A, O’Neill C, Meinecke B, Wolfe P, Zhu Z, Jiang W (2005) 8-Isoprostane F2alpha excretion is reduced in women by increased vegetable and fruit intake. Am J Clin Nutr 82(4):768–776Google Scholar
  53. 53.
    Brevik A, Gaivão I, Medin T, Jørgenesen A, Piasek A, Eliasson J, Karlsen A, Blomhoff R, Veggan T, Duttaroy AK, Collins AR (2011) Supplementation of a western diet with golden kiwifruits (Actinidia chinensis var’.Hort 16A’:) effects on biomarkers of oxidation damage and antioxidant protection. Nutr J 18(10):54CrossRefGoogle Scholar
  54. 54.
    Riso P, Martini D, Møller P, Loft S, Bonacina G, Moro M, Porrini M (2010) DNA damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis 25(6):295–602CrossRefGoogle Scholar
  55. 55.
    Møller P, Vogel U, Pedersen A, Dragsted LO, Sandström B, Loft S (2003) No effect of 600 grams fruit and vegetables per day on oxidative DNA damage and repair in healthy nonsmokers. Cancer Epi Biomark Prev 12:1016–1022Google Scholar
  56. 56.
    Huang HY, Helzlsouer KJ, Appel LJ (2000) The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 7:647–652Google Scholar
  57. 57.
    Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald GA (2001) Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285(9):1178–1182CrossRefGoogle Scholar
  58. 58.
    Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, Stuehlinger M, Lin KY, Cooke JP, Morrow JD, Ridker PM, Rifai N, Miller E, Witztum JL, Mietus-Snyder M (2003) Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 108(9):1059–1063CrossRefGoogle Scholar
  59. 59.
    Thomson CA, Stendell-Hollis NR, Rock CL, Cussler EC, Flatt SW, Pierce JP (2007) Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev 10:2008–2015CrossRefGoogle Scholar
  60. 60.
    Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P (2008) The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 45(4):377–384CrossRefGoogle Scholar
  61. 61.
    Lean MEJ, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A (1999) Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48:176–181CrossRefGoogle Scholar
  62. 62.
    Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, Musaeus N, Krinsky NI, Russell RM, Yeum KJ (2006) Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin NutrJan 83(1):163–169Google Scholar
  63. 63.
    Crane TE, Kubota C, West JL, Kroggel MA, Wertheim BC, Thomson CA (2011) Increasing the vegetable intake dose is associated with a rise in plasma carotenoids without modifying oxidative stress or inflammation in overweight or obese postmenopausal women. J Nutr 141(10):1827–1833CrossRefGoogle Scholar
  64. 64.
    Moon RC, Mehta RG (1989) Chemoprevention of experimental carcinogenesis in animals. Prev Med 18(5):576–591CrossRefGoogle Scholar
  65. 65.
    Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Boone CW, Malone WA, Hawk ET, Lieberman R, Lawrence JA, Kopelovich L, Ali I, Viner JL, Sigman CC (1999) Progress in cancer chemoprevention. Ann N Y Acad Sci 889:1–13CrossRefGoogle Scholar
  66. 66.
    Abdulla M, Gruber P (2000) Role of diet modification in cancer prevention. BioFactors 12(1–4):45–51CrossRefGoogle Scholar
  67. 67.
    Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145–1149CrossRefGoogle Scholar
  68. 68.
    Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP (1997) Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349(9067):1715–1720CrossRefGoogle Scholar
  69. 69.
    Leppälä JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, Heinonen OP (2000) Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 1:230–235CrossRefGoogle Scholar
  70. 70.
    Törnwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Taylor PR, Albanes D, Huttunen JK (2004) Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur Heart J 25(13):1171–1178CrossRefGoogle Scholar
  71. 71.
    Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, Valanis B, Williams JH Jr (2004) The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 96(23):1743–1750CrossRefGoogle Scholar
  72. 72.
    West KP Jr, Christian P, Labrique AB, Rashid M, Shamim AA, Klemm RD, Massie AB, Mehra S, Schulze KJ, Ali H, Ullah B, Wu LS, Katz J, Banu H, Akhter HH, Sommer A (2011) Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in rural Bangladesh: a cluster randomized trial. JAMA 305(19):1986–1995CrossRefGoogle Scholar
  73. 73.
    Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347(9004):781–786CrossRefGoogle Scholar
  74. 74.
    GISSI (1999) Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354(9177):447–455CrossRefGoogle Scholar
  75. 75.
    Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342(3):154–160CrossRefGoogle Scholar
  76. 76.
    Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the women’s health study: a randomized controlled trial. JAMA 294(1):56–65CrossRefGoogle Scholar
  77. 77.
    Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142(1):37–46Google Scholar
  78. 78.
    Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, Johnson LL, Gail MH, Dong ZW, Yu B, Mark SD, Taylor PR (2009) Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 101(7):507–518CrossRefGoogle Scholar
  79. 79.
    Clemons TE, Kurinij N, Sperduto RD (2004) AREDS Research Group. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the age-related eye disease. Arch Ophthalmol 122(5):716–726CrossRefGoogle Scholar
  80. 80.
    Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE (2008) Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 300(17):2012–2021CrossRefGoogle Scholar
  81. 81.
    Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 25; 276(24):1957–1963Google Scholar
  82. 82.
    Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark LC, Reid ME (2006) Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 163(8):694–699CrossRefGoogle Scholar
  83. 83.
    Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, Touvier M, Favier A, Latino-Martel P, Briançon S, Galan P (2010) Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a post-intervention follow-up in the SU.VI.MAX study. Int J Cancer 127(8):1875–1881CrossRefGoogle Scholar
  84. 84.
    Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):23–33CrossRefGoogle Scholar
  85. 85.
    Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK (1996) Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88(21):1560–1570CrossRefGoogle Scholar
  86. 86.
    Woodson K, Stewart C, Barrett M (1999) Effect of Vitamin Intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers. Cancer Epidemiol Biomarkers Prev 8:965–970Google Scholar
  87. 87.
    Virtamo J, Edwards BK, Virtanen M, Taylor PR, Malila N, Albanes D, Huttunen JK, Hartman AM, Hietanen P, Mäenpää H, Koss L, Nordling S, Heinonen OP (2000) Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control 11(10):933–939CrossRefGoogle Scholar
  88. 88.
    Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P, ATBC Study Group (2003) Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290(4):476–485CrossRefGoogle Scholar
  89. 89.
    Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334(18):1150–1155CrossRefGoogle Scholar
  90. 90.
    Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist M, Goodman GG (2009) Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 18(8):2202–2206CrossRefGoogle Scholar
  91. 91.
    Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the women’s health study: a randomized controlled trial. JAMA 294(1):56–65CrossRefGoogle Scholar
  92. 92.
    Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P, Hercberg S (2010) Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 127(1):172–184CrossRefGoogle Scholar
  93. 93.
    Fritz H, Kennedy D, Fergusson D, Fernandes R, Doucette S, Cooley K, Seely A, Sagar S, Wong R, Seely D (2011) Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis. PLoS ONE 6(6):e21107CrossRefGoogle Scholar
  94. 94.
    Jeon YJ, Myung SK, Lee EH, Kim Y, Chang YJ, Ju W, Cho HJ, Seo HG, Huh BY (2011) Effects of beta-carotene supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr CancerNov 63(8):1196–1207CrossRefGoogle Scholar
  95. 95.
    Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE (2009) Vitamins E and C in the prevention of prostate and total cancer in men: the physicians’ health study II randomized controlled trial. JAMA 301(1):52–62CrossRefGoogle Scholar
  96. 96.
    Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH (2011) Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306(14):1549–1556CrossRefGoogle Scholar
  97. 97.
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2008) Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 16(3):CD004183Google Scholar
  98. 98.
    Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, Tappenden P, Logan RF (2011) Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis 13(10):1085–1099CrossRefGoogle Scholar
  99. 99.
    Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11(7):630–639Google Scholar
  100. 100.
    Fritz H, Kennedy D, Fergusson D, Fernandes R, Cooley K, Seely A, Sagar S, Wong R, Seely D (2011) Selenium and lung cancer: a systematic review and meta analysis. PLoS One 6(11):e26259CrossRefGoogle Scholar
  101. 101.
    Taylor PR, Li Bing, Dawsey Sanford M, Li Jun-Yao, Yang Chung S, Guo Wande, Blot William J (1994) Linxian Nutrition Intervention Trials Study Group Prevention of Esophageal Cancer: the Nutrition Intervention in Linxian, China. Cancer Res 54(suppl.):2029 s–2031 sGoogle Scholar
  102. 102.
    Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, Buring JE, Manson JE (2009) Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 101(1):14–23CrossRefGoogle Scholar
  103. 103.
    Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE (2008) Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 300(17):2012–2021CrossRefGoogle Scholar
  104. 104.
    Myung SK, Ju W, Kim SC (2011) Korean Meta-analysis (KORMA) Study Group. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis. BJOG 118(11):1285–1291CrossRefGoogle Scholar
  105. 105.
    Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2010) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. The Cochrane Collaboration, issue 1, Wiley, New YorkGoogle Scholar
  106. 106.
    Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334(18):1150–1155CrossRefGoogle Scholar
  107. 107.
    Blot WJ, Li J-Y, Taylor PR, Guo W, Dawsey S, Wang G-Q, Yang CS, Zheng S-F, Gail M, Li G-Y, Yu Y, Liu B-Q, Tangrea J, Sun Y-H, Liu F, Fraumeni JF, Zhang Y-H, Li B (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J Natl Cancer Inst 85:1483–1492CrossRefGoogle Scholar
  108. 108.
    The α-Tocopherol and β-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 330:1029–1035CrossRefGoogle Scholar
  109. 109.
    Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475(7355):231–234CrossRefGoogle Scholar
  110. 110.
    Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R (2011) Rapamycin, but not resveratrol or simvastatin, extends lifespan of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66(2):191–201CrossRefGoogle Scholar
  111. 111.
    Dipartimento Sanita’ Pubblica Veterinaria, Sicurezza Alimentare E Organi Collegiali Per La Tutela Della Salute. Direzione Generale Igiene E Sicurezza Degli Alimenti E Della Nutrizione Commissione Unica Per La Dietetica E La Nutrizione. Uso Di Prodotti Naturali Come Tisane Ed Integratori Alimentari Da Parte Dei Gruppi Più Vulnerabili Della Popolazione Come Bambini E Donne In Gravidanza O Durante L’allattamento. Ministero Della Salute, Rome, Italy, 2012Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Piero Dolara
    • 1
  • Elisabetta Bigagli
    • 1
  • Andrew Collins
    • 2
    • 3
  1. 1.Department of Preclinical and Clinical PharmacologyFlorenceItaly
  2. 2.Department of NutritionUniversity of OsloOsloNorway
  3. 3.School of Medical SciencesUniversity of AucklandAucklandNew Zealand

Personalised recommendations